190
Participants
Start Date
December 31, 2007
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Keppra XR (Levetiracetam XR)
500 mg tablets, 1000 - 3000 mg/day, flexible dosing for duration of the study (planned: approximately 6 months-3 years).
Dothan
Northport
Phoenix
Little Rock
Bakersfield
Loxahatchee Groves
Atlanta
Suwanee
Witchita
Detroit
Camden
Buffalo
Cedarhurst
Toledo
Tulsa
San Antonio
Aguascalientes
Guadalajara
Guadalajara Jalisco
Mexico City
Monterrey
Bialystok
Gdansk
Katowice
Lodz
Lublin
Poznan
Szczecin
Warsaw
Kalingrad
Kazan'
Moscow
Saint Petersburg
Samara
Yaroslavl
Lead Sponsor
UCB Pharma
INDUSTRY